You just read:

New Phase 2b Analysis Suggests AEROSURF® may Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS

News provided by

Windtree Therapeutics, Inc.

May 09, 2019, 19:34 ET